Back to Search
Start Over
High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
- Source :
-
Microbial drug resistance (Larchmont, N.Y.) [Microb Drug Resist] 2017 Oct; Vol. 23 (7), pp. 838-844. Date of Electronic Publication: 2017 Feb 13. - Publication Year :
- 2017
-
Abstract
- The emergence and spread of carbapenem-resistant gram-negative bacteria poses a serious threat to human health worldwide. Currently, little is known about the molecular mechanisms underlying carbapenem resistance and their prevalence among gram-negative bacteria in Egypt. In this study, we analyzed carbapenemase production in gram-negative bacteria isolated from hospitalized patients in Egypt in 2014. All isolates were subjected to phenotypic and genotypic susceptibility testing for carbapenem resistance. Our results indicated a high level of carbapenem-resistant gram-negative bacteria in Egypt, with 50.8% of the isolates harboring at least one carbapenem resistance gene. OXA-48-like and NDM-1 were the most prevalent carbapenemases, being detected in 49.2%, and 47.7% of carbapenemase-positive isolates, respectively, whereas Verona integron-encoded metallo-β-lactamase (VIM) was detected in only 26.2% of carbapenemase-positive isolates. This study reports for the first time carbapenemase-producing Serratia marcescens, Morganella morganii, and bla <subscript>VIM-1-like</subscript> -producing Pseudomonas aeruginosa in Egypt. It is also the first demonstration of the coexistence of different carbapenemases, being detected in 21.5% of carbapenemase-positive isolates. Effective antibiotic supervision, regional surveillance, and early detection of carbapenemase producers are imperative to prevent their future spread to epidemic levels.
- Subjects :
- Anti-Bacterial Agents pharmacology
Carbapenems pharmacology
Egypt epidemiology
Enterobacteriaceae Infections drug therapy
Enterobacteriaceae Infections epidemiology
Enterobacteriaceae Infections microbiology
Escherichia coli classification
Escherichia coli drug effects
Escherichia coli isolation & purification
Escherichia coli Infections drug therapy
Escherichia coli Infections epidemiology
Escherichia coli Infections microbiology
Gene Expression
Hospitals
Humans
Integrons
Microbial Sensitivity Tests
Morganella morganii classification
Morganella morganii drug effects
Morganella morganii isolation & purification
Phylogeny
Pseudomonas Infections drug therapy
Pseudomonas Infections epidemiology
Pseudomonas Infections microbiology
Pseudomonas aeruginosa classification
Pseudomonas aeruginosa drug effects
Pseudomonas aeruginosa isolation & purification
Serratia Infections drug therapy
Serratia Infections epidemiology
Serratia Infections microbiology
Serratia marcescens classification
Serratia marcescens drug effects
Serratia marcescens isolation & purification
beta-Lactamases metabolism
Escherichia coli genetics
Morganella morganii genetics
Pseudomonas aeruginosa genetics
Serratia marcescens genetics
beta-Lactam Resistance genetics
beta-Lactamases genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1931-8448
- Volume :
- 23
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Microbial drug resistance (Larchmont, N.Y.)
- Publication Type :
- Academic Journal
- Accession number :
- 28191865
- Full Text :
- https://doi.org/10.1089/mdr.2015.0339